drug · small molecule
aldoxorubicin
Phase 3updated 3mo agoby LadRx Corp🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 6 investigational indications.
targets
DNA topoisomerase 2-alpha
all catalysts(0)
nothing on the calendar yet
Trials studying aldoxorubicin
- phase2Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- phase2QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
- phase2QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
- phase2QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
- phase2QUILT-3.088: NANT Pancreatic Cancer Vaccine
- phase2QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- phase2QUILT-3.080: NANT Pancreatic Cancer Vaccine
- phase2QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that